NASDAQ · Financial Statements
MedTech Acquisition Corporation (MTACW) Financial Statements
$0.22
NASDAQ: MTACW
Overview Financials Dividend
MedTech Acquisition Corporation most recently reported annual revenue of $45.0M, a net loss of $39.0M. See the full income statement, balance sheet, and cash flow statement below, plus valuation and return ratios.
Annual Financials (USD)
Metric 2021 2022 2023 2024 2025
Revenue $8.0M $12.0M $19.0M $29.0M $45.0M Operating Profit $-24.0M $-36.0M $-54.0M $-36.0M $-27.0M Net Profit $-29.0M $-47.0M $-59.0M $-33.0M $-39.0M EPS $-0.92 $-1.59 $-2.23 $-1.25 $-1.84 Op Margin -286.1% -293.9% -294.3% -122.9% -59.7%
Balance Sheet (USD)
Metric 2021 2022 2023 2024 2025
Total Assets $38.0M $22.0M $25.0M $24.0M $35.0M Total Liabilities $7.0M $34.0M $52.0M $50.0M $69.0M Cash $30.0M $9.0M $12.0M $9.0M $20.0M Borrowings $0 $2.0M $2.0M $24.0M $34.0M
Cash Flow (USD)
Metric 2021 2022 2023 2024 2025
Operating Cash Flow $-23.0M $-32.0M $-51.0M $-41.0M $-18.0M Investing Cash Flow $-4.0M $-3.0M $-2.0M $-1.0M $-2.0M Financing Cash Flow $0 $0 $46.0M $-3.0M $-2.0M Net Cash Flow $26.0M $-21.0M $2.0M $-3.0M $12.0M Free Cash Flow $-24.0M $-33.0M $-51.0M $-41.0M $-19.0M
Valuation & Return Ratios
Metric Value PEG Ratio 0.00 EV / EBITDA 1.14 FCF Yield — Quick Ratio 4.97 Interest Coverage 10.46 Return 1Y — Return 3Y — Return 5Y —
Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer .